Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,607 | -1,697 | -6,223 | -4,234 | -2,424 |
| Depreciation Amortization | 14 | 7 | 6 | 3 | 2 |
| Other Working Capital | -2,495 | -221 | -596 | -376 | -317 |
| Other Operating Activity | 264 | 122 | 81 | -158 | -443 |
| Operating Cash Flow | $-6,824 | $-1,788 | $-6,732 | $-4,766 | $-3,181 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,756 | -10,823 | -11,277 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -129 | 0 |
| Investing Cash Flow | $3,756 | $-10,823 | $-11,277 | $-129 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,190 | 3,893 | 30,634 | 5,696 | 204 |
| Other Financing Activity | -14 | -6 | 2,658 | 2,682 | 2,682 |
| Financing Cash Flow | $4,176 | $3,887 | $33,293 | $8,378 | $2,886 |
| Exchange Rate Effect | 10 | -28 | -2 | 5 | -1 |
| Beginning Cash Position | 17,039 | 16,376 | 1,783 | 1,797 | 1,796 |
| End Cash Position | 18,157 | 7,625 | 17,064 | 5,284 | 1,500 |
| Net Cash Flow | $1,118 | $-8,751 | $15,282 | $3,488 | $-296 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,824 | -1,788 | -6,732 | -4,766 | -3,181 |
| Free Cash Flow | -6,824 | -1,788 | -6,732 | -4,766 | -3,181 |